References
- Spasic B. Why Serbs are disappearing?. 9. edition. Kragujevac: Printing house Skver. 2009. pp 39–41.
- Institute of Public Health of Serbia “dr Milan Јovanovic Batut”. Health statistical yearbook of Republic of Serbia for 2010. year. Belegrade: Available at
http://www.batut.org.rs/download/aktuelno , Last visited: 10.04.2020. - Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev 2011. 10(4):430–439.
- Nezić L. Clinical pharmacology in geriatrics. Medical Faculty of Banja Luka. 2018. pp: 20–1
- Janković MS. Pharmacology and Toxicology. Medical Faculty Kragujevac, 2011. pp: 59–60.
- Louis-Simonet M, Kossovsky MP, Sarasin FP, Chopard P, Gabriel V, Perneger TV, et al. Effects of a structured patient-centered discharge interview on patients’ knowledge about their medications. Am J Med 2004; 117(8):563–568
- Galvin R, Moriarty F, Cousins G, Cahir C, Motterlini N, Bradley M, et al. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA). Eur J Clin Pharmacol 2014; 70(5):599–606.
- Oxford academic. Age and Ageing. STOPP and START criteria 2015. Available at:
https://www.farmaka.be/frontend/files/publications/files/liste-stopp-start-version-2.pdf? Last visited: 19. 12. 2020. - Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Beh Res Methods 2007; 39(2):175–191.
- Kovačević VS., Simišić M., Stojkov RS., et al. Potentially Inappropriate Prescribing in Older Primary Care Patients. 2014. 9: 4 (e95536).
- Xhyljeta Luta, Christophe Bagnoud, Mark Lambiris et al. Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data. BMJ Open. 2020. 10(1): e031156.
- Donovan T. Maust, Frederic C. Blow, Ilse R. Wiechers, Helen C. Kales, Steven C. Marcus. National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary Care. J Clin Psychiatry. 2017. 78(4): e363–e371.
- Leo A Coleman, Jonathan Brett, Benjamin J Daniels, Michael O Falster. Medicine reviews: do they reduce benzodiazepine use in older Australians? 2021. 8;31(3):30452015.
- Xiao-Mei Zhong, Fei Wang, Qinge Zhang et al. Concurrent benzodiazepine use in older adults treated with antidepressants in Asia. 2019. 31(5):685–691.
- Rebecca Hedrick, Samuel Korouri, Emile Tadros et al. The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure. Drugs in Context 2020. 9: 2020-5-4.
- Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, Niklas Schmedt. Antidepressants and the risk of death in older patients with depression: A population-based cohort study. 2019. PLoS ONE 14(4): e0215289.
- Projovic I., Vukadinovic D., Milovanovic O., et al. Risk factors for potentially inappropriate prescribing to older patients in primary care. Eur J Clin Pharmacol. 2016. 72(1):93–107.
- Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry A. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med 2010. 7(10):e1000352.
- Iria Fernández-Álvarez, Maruxa Zapata-Cachafeiro, Juan Vázquez-Lago et al. Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care. PLoS One. 2019. 22;14(8):e0221326.
- Samardžić J., Zeković J., Stevanović A., Jančić j., Dimitrijević I. Benzodiazepine (ab)use and addictive potential: Analyses of consumption in Serbia for the period 2014–2016. Engrami. 2018.40: (2).
- Balon R., Chouinard G., Cosci F., et al. International Task Force on Benzodiazepines. Psychother Psychosom 2018. 87(4):193–94.